Health Care · owned by 1 fund manager
Who owns Beam Therapeutics (BEAM)?
1 of the 22 fund managers we track hold Beam Therapeutics, worth $5M combined as of Q2 2026. Stanley Druckenmiller has the biggest bet at 0.1% of the portfolio.
Ownership summary
Fund manager owners
1 / 22
1 opened new positions
Combined value
$5M
At quarter-end prices
Biggest weight
0.1%
Stanley Druckenmiller
Buyers / sellers
1 / 0
Changes in Q2 2026
Smart money take
Why it matters
When several investors with very different styles own the same company, it’s often worth a closer look. Beam Therapeutics appears in 1 of our 22 portfolios.
- Largest holder: Stanley Druckenmiller (0.1% of portfolio)
- 1 manager bought or added this quarter
- 0 managers trimmed or sold out
- Company insiders in Q3 2026: no open-market buys, sold $2M
This is not a recommendation. Do your own research.
Fund managers who own BEAM
SEC 13F · Q2 2026| Investor | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Stanley Druckenmiller Duquesne Family Office | 0.10% | New | 153,600 | $5M |
Coming soon · QWERTx Pro
Professionally managed portfolios, built around your life.
We are building QWERTx Pro: portfolios matched to your risk profile and time horizon, managed by experienced financial advisors. Join the waitlist to hear first when it launches.
